CHINA PHARMA HOLDINGS, INC. Other Notes Payable
CHINA PHARMA HOLDINGS, INC. (CPHI) had Other Notes Payable of $959.51 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:OtherNotesPayable · last filed 2023-08-14
- 2023-06-30: Other Notes Payable $959.51K.
- 2023-03-31: Other Notes Payable $955.51K.
- 2022-12-31: Other Notes Payable $951.51K.
- 2022-03-31: Other Notes Payable $719.51K.
| Period end | Other Notes Payable | Other Notes Payable as first filed |
|---|---|---|
| 2023-06-30 | $959.51K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $955.51K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $951.51K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $719.51K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $715.51K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $645.33K 10-Q · filed 2021-11-12 | |
| 2021-03-31 | $1.82M 10-Q · filed 2021-08-13 | $1.66M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.66M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $2.32M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $2.32M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $2.31M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $2.31M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $2.06M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.06M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.06M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.07M 10-K · filed 2020-03-30 | $2.05M 10-K · filed 2019-03-28 |
| 2017-12-31 | $1.82M 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |